HEPARIN AS A RISK FACTOR FOR PERIGRAFT SEROMA COMPLICATING THE MODIFIED BLALOCK-TAUSSIG SHUNT
Open Access
- 1 August 1998
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 116 (2) , 286-293
- https://doi.org/10.1016/s0022-5223(98)70129-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Surgery for congential heart disease Unifocalization for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteriesThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Successful treatment of leakage of serous fluid following construction of a polytetrafluorethylene central shuntCardiology in the Young, 1995
- Shunts and security—the polytetrafluoroethylene leakCardiology in the Young, 1995
- The isolation of a fibroblast growth inhibitor associated with perigraft seromaJournal of Vascular Surgery, 1994
- Lymphatic fistula and perigraft seromaBritish Journal of Surgery, 1993
- Perigraft seroma diagnosed by echocardiography: a complication following Blalock-Taussig shuntInternational Journal of Cardiology, 1992
- Biochemical analysis of a human humoral fibroblast inhibitory factor associated with impaired vascular prosthetic graft incorporationJournal of Vascular Surgery, 1991
- Perigraft seroma: Clinical, histologic, and serologic correlatesThe American Journal of Surgery, 1987
- Computerized tomographic assessment of graft incorporation after aortic reconstructionThe American Journal of Surgery, 1985
- Fibroblast inhibition: A new and treatable cause of prosthetic graft failureThe American Journal of Surgery, 1985